10-87952260-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000314.8(PTEN):c.634+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000314.8 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8 | c.634+1G>T | splice_donor_variant, intron_variant | Intron 6 of 8 | ENST00000371953.8 | NP_000305.3 | ||
| PTEN | NM_001304717.5 | c.1153+1G>T | splice_donor_variant, intron_variant | Intron 7 of 9 | NP_001291646.4 | |||
| PTEN | NM_001304718.2 | c.43+1G>T | splice_donor_variant, intron_variant | Intron 6 of 8 | NP_001291647.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 31 
GnomAD4 genome  
ClinVar
Submissions by phenotype
not provided    Pathogenic:2 
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18080326, 28677221, 16014636, 21194675) -
This variant is located in a canonical splice-donor site and interferes with normal PTEN mRNA splicing. The variant has been reported in an individual with Cowden syndrome (PMID: 21194675 (2011)). A different variant at the same nucleotide position, c.634+1G>C, is described in an online database as being pathogenic (ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/)). Based on the available information, the c.634+1G>T variant is classified as pathogenic. -
PTEN hamartoma tumor syndrome    Pathogenic:1 
Disruption of this splice site has been observed in individuals with PTEN-related conditions (PMID: 21194675, 23470840, 28677221). This sequence change affects a donor splice site in intron 6 of the PTEN gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 1317879). Studies have shown that disruption of this splice site results in skipping of exon 6 and introduces a premature termination codon (Invitae). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome    Pathogenic:1 
The c.634+1G>T intronic pathogenic mutation results from a G to T substitution one nucleotide after coding exon 6 of the PTEN gene. Designated as IVS6+1G>T, this alteration was seen in a cohort of patients with Cowden syndrome (CS) or Bannayan-Riley-Ruvalcaba syndrome (BRRS), and RNA analysis demonstrated that it resulted in out-of-frame skipping of exon 6 (Agrawal S et al. Hum. Mol. Genet., 2005 Aug;14:2459-68). Two other alterations at this splice site, c.634+1G>C and c.634+5G>A, were also seen in individuals affected with CS or BRRS and were also demonstrated to result in exon 6 skipping (Boccone L et al. Am. J. Med. Genet. A, 2008 Jan;146A:257-60; Chen HJ et al. Hum. Mutat., 2017 10;38:1372-1377). In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at